电针调节筋膜修复机制:大鼠胸腰筋膜炎模型预实验
本研究用42只Sprague-Dawley大鼠建立胸腰筋膜炎模型,观察电针BL23与BL40对筋膜修复的影响。电针组每日20分钟连续9天,结果显示机械痛敏降低、筋膜厚度减小、促炎因子与成纤维细胞活性标志物表达下降,细胞外基质成分平衡改善,可能与抑制TGF-β1/Smad2通路有关。
要点
- 电针BL23与BL40可减轻胸腰筋膜炎大鼠的机械痛敏并降低筋膜厚度。
- 电针抑制促炎因子及成纤维细胞增殖活化标志物表达,促进筋膜修复。
- 电针改善细胞外基质平衡,其机制可能与下调TGF-β1/Smad2通路活性有关。
核心结论
- 电针BL23与BL40可减轻炎症、抑制成纤维细胞增殖活化并促进筋膜修复,可能通过调节TGF-β1/Smad2通路实现。
- 结果支持电针治疗肌筋膜炎的潜在治疗价值,可能有助于慢性肌肉骨骼疼痛管理与筋膜组织修复。
研究设计与样本
- 预实验采用42只六周龄Sprague-Dawley大鼠,分为对照组(n=15)与造模组(n=27)。
- 通过向胸腰筋膜注射完全弗氏佐剂诱导胸腰筋膜炎模型,对照组与造模组各取3只用于模型验证。
- 其余24只造模大鼠分为模型组与电针组(各n=12),电针组于BL23与BL40电针20分钟/日,连续9天。
- 评估包括皮肤痛敏、肌骨超声、筋膜厚度组织学评价、炎症标志物及成纤维细胞活性测定。
主要发现
- 电针组大鼠机械痛敏降低、筋膜厚度减小。
- 电针组促炎标志物肿瘤坏死因子-α与白介素1β表达降低。
- 电针组成纤维细胞活性标志物增殖细胞核抗原、α-平滑肌肌动蛋白与波形蛋白表达降低。
- 电针组细胞外基质成分呈有利平衡:I/III型胶原比值及基质金属蛋白酶-1/组织金属蛋白酶抑制剂-1比值升高,与TGF-β1/Smad2通路活性降低相关。
临床怎么用
- 结果提示电针BL23与BL40可能作为肌筋膜炎及慢性肌肉骨骼疼痛的辅助治疗思路。
- 机制上可关注电针对TGF-β1/Smad2通路的调节作用及对成纤维细胞活化的抑制。
局限性
- 本研究为动物预实验,样本量有限,结论需进一步临床研究验证。
- 原文未报告具体疼痛阈值、筋膜厚度数值、炎症标志物定量数据及统计P值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Myofasciitis, a prevalent cause of musculoskeletal pain, is associated with thoracolumbar fascial changes. Acupuncture is effective for pain relief, but its role in fascial repair remains unclear. This study examined the effects of electroacupuncture (EA) at BL23 (Shenshu) and BL40 (Weizhong) on fascial tissue repair in a rat model of thoracolumbar fasciitis (TLF). METHODS: The study involved 42 six-week-old Sprague-Dawley rats divided into control (n = 15) and modeling (n = 27) groups. TLF was induced by injecting complete Freund's adjuvant into the thoracolumbar fascia. Three rats in the control and modeling groups were used for model validation. The remaining 24 modeled rats were split into model and EA groups (n = 12 each). EA was administered at BL23 and BL40 to rats in the EA group for 20 min daily for 9 days. Assessments included skin pain sensitivity, musculoskeletal ultrasound, histological evaluation of fascial thickness, and measurement of inflammatory markers and fibroblast activity. RESULTS: EA-treated rats showed significant improvements, including reduced mechanical pain sensitivity, decreased fascial thickness and lower expression of pro-inflammatory markers (tumor necrosis factor-α, interleukin 1β) and fibroblast activity markers (proliferating cell nuclear antigen, α-smooth muscle actin, and vimentin). There was also a favorable balance in extracellular matrix components (increased type I/III collagen and matrix metalloproteinase (MMP)-1/tissue inhibitor of MMP (TIMP)-1 ratios), which was linked to reduced activity of the transforming growth factor (TGF)-β1/suppressor of mother against decapentaplegic (Smad)2 pathway. CONCLUSION: EA at BL23 and BL40 reduces inflammation, inhibits fibroblast proliferation and activation, and promotes fascial repair, likely via modulation of the TGF-β1/Smad2 pathway. These findings support the therapeutic potential of EA for the treatment of myofasciitis, potentially aiding in chronic musculoskeletal pain management and fascial tissue repair.
引用
- Tong X, Yu D, Chen J, et al. Modulatory mechanisms of electroacupuncture in fascial tissue repair: a pilot study using a rat model of thoracolumbar fasciitis. Acupunct Med. 2026. PMID: 41562149. doi:10.1177/09645284251410580
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。